Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Unterrainer

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2019
In response to: The validity of <sup>18</sup>F-GE180 as a TSPO imaging agentNathalie L Albert, Marcus Unterrainer, Matthias Brendel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate CancerLena M Unterrainer, Honest Ndlovu, Thomas A Hope, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2020
First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&T in Advanced-mCRPC PatientsMathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, et al.
Seminars in Nuclear Medicine|March 10, 2025
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation TherapyCedric Richlitzki, Farkhad Manapov, Adrien Holzgreve, et al.
Clinical Nuclear Medicine|August 16, 2023
Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99m Tc-DPD ScintigraphySophie C Kunte, Stéphanie K Schwarting, Adrien Holzgreve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
<sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical UseHannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, et al.
Radiologie (Heidelberg, Germany)|October 20, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Siegmund, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Urologie (Heidelberg, Germany)|August 18, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Kunte, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Clinical Nuclear Medicine|September 5, 2018
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT ExpressionMarcus Unterrainer, Caroline Diekmann, Mario Dorostkar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CTMichael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2019
In response to: The validity of <sup>18</sup>F-GE180 as a TSPO imaging agentNathalie L Albert, Marcus Unterrainer, Matthias Brendel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate CancerLena M Unterrainer, Honest Ndlovu, Thomas A Hope, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2020
First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&T in Advanced-mCRPC PatientsMathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, et al.
Seminars in Nuclear Medicine|March 10, 2025
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation TherapyCedric Richlitzki, Farkhad Manapov, Adrien Holzgreve, et al.
Clinical Nuclear Medicine|August 16, 2023
Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99m Tc-DPD ScintigraphySophie C Kunte, Stéphanie K Schwarting, Adrien Holzgreve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
<sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical UseHannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, et al.
Radiologie (Heidelberg, Germany)|October 20, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Siegmund, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Urologie (Heidelberg, Germany)|August 18, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Kunte, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Clinical Nuclear Medicine|September 5, 2018
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT ExpressionMarcus Unterrainer, Caroline Diekmann, Mario Dorostkar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CTMichael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Pageof 17